REG-BARCLAYS PLC Form 38.5(b) REPORT - OSMOTICA PHARMACEUTICALS PLC

BarclaysAnnouncement

01/04/2021 11:20

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210401:nBw1x4rNna&default-theme=true


Form 38.5(b) REPORT - OSMOTICA PHARMACEUTICALS PLC

 

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY
STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A
CLIENT-SERVING CAPACITY

1. KEY INFORMATION
 Name of exempt principal trader:         BARCLAYS CAPITAL INC          
 Company dealt in                         OSMOTICA PHARMACEUTICALS PLC  
 Class of relevant security to which the  US$0.01 ordinary shares       
 dealings being disclosed relate          
 Date of dealing                          31 March 2021                 


2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 2)
 Class of relevant security:                        ORD                                
                                                    Interests      Short Positions     
                                                    Number  (%)    Number    (%)       
 (1)             Relevant securities owned                                             
                                                    320     0.00%  0         0.00%     
                                                                                       
 (2)             Derivatives (other than options):                                     
                                                    0       0.00%  0         0.00%     
                                                                                       
 (3)             Options and agreements to                                             
                 purchase/sell:                     0       0.00%  0         0.00%     
                                                                                       
                                                                                       
                 TOTAL:                             320     0.00%  0         0.00%     
                                                                                       


b. Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 2)
 Class of relevant security:                  Long             Short            
                                              Number      (%)  Number      (%)  
 (1) Relevant securities                                                        
 (2) Derivatives (other than options)                                           
 (3) Options and agreements to purchase/sell                                    
 Total                                                                          
                                                                                


3. DEALINGS (Note 3)

a. Purchases and sales
 Purchase/sale  Number of   Price per unit  
                securities                  
 Purchase       5           3.2600 USD      
 Purchase       88          3.2300 USD      
 Purchase       100         3.2950 USD      
 Purchase       212         3.2580 USD      
 Purchase       300         3.2816 USD      
 Purchase       300         3.2433 USD      
 Purchase       400         3.2350 USD      
 Purchase       1,909       3.2356 USD      
 Sale           5           3.2600 USD      
 Sale           3,309       3.2435 USD      


b. Derivatives transactions (other than options transactions)
 Product name,  Nature of transaction  Number of relevant securities  Price per unit  
 
              
                      
                              
               
 e.g. CFD       (Note 5)               (Note 6)                       (Note 4)        
                                                                                      


c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying
 Product name,      Writing, selling, purchasing, varying etc.  Number of securities to which the option relates (Note 7)  Exercise price  Type, e.g. American, European etc.  Expiry date  Option money paid/received per unit (Note 4)  
 
                                                                                                                                                                                                                                        
 e.g. call option                                                                                                                                                                                                                         
                                                                                                                                                                                                                                          


ii. Exercising
 Product name,      Number of securities  Exercise price per unit (Note 4)  
 
                                                                          
 e.g. call option                                                           
                                                                            


d. Other dealings (including transactions in respect of new securities) (Note
3)
 Nature of transaction  Details  Price per unit             
 
                               
                          
 (Note 7)                        (if applicable) (Note 4)   
                                                            
                                 
                          
                                                            


4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.

None
 Is a Supplemental Form 38.5(b) attached?      NO                                    
 Date of disclosure:                           01 Apr 2021                           
 Contact name:                                 Large Holdings Regulatory Operations  
 Telephone number:                             020 3134 7213                         
 Name of offeree/offeror with which connected                                        
 Nature of connection                                                                


 



View source version on businesswire.com:
https://www.businesswire.com/news/home/20210401005360/en/
(https://www.businesswire.com/news/home/20210401005360/en/)

BARCLAYS PLC


Copyright Business Wire 2021